Detection of early-stage age related macular degeneration with a compact rarebit test
Department of Ophthalmology, Academic Medical Center, University of Amsterdam, P.O. Box 22700, Amsterdam, NL-1100 DE, The NetherlandsThe British journal of ophthalmology (Impact Factor: 2.81). 08/2012; 96(10):1354-5. DOI: 10.1136/bjophthalmol-2012-301735
Full-textDOI: · Available from: Ton G van Leeuwen, Nov 04, 2014
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
- [Show abstract] [Hide abstract]
ABSTRACT: OBJECTIVE: Rapid assessments of vision commonly rely on visual acuity testing alone. Although well suited for uncovering optical defects, visual acuity tests may fail to detect dysfunction of the neural substrate. There is a need for a rapid companion test sensitive to neural damage. DESIGN: Evaluation of diagnostic tests. PARTICIPANTS AND CONTROLS: Forty-seven patients with optic nerve or visual pathway lesions of low to moderate severities and 30 normal subjects. METHODS: A new computer-based quick test of neurovisual integrity was developed using segmented digits defined by rarebits, that is, receptive field-size bright dots briefly presented on a dark background. MAIN OUTCOME MEASURES: The test variable was the number of rarebits per segment; digit size was fixed. The test task was to call out verbally all digits that were seen during an 8-second presentation sequence. Test outcomes were contrasted with the results of an optotype acuity test and automated perimetry. RESULTS: All subjects easily grasped the test task. The normal subjects read, on average, 5.6 (±0.5 standard deviation) of the 6 digits contained in the test sequence, whereas the patients averaged 3.3±1.8 digits. The numbers of digits read correlated modestly with the acuity and perimetry results. Analysis of receiver operating characteristic curves indicated that the multiple rarebit test provided the best discrimination. CONCLUSIONS: The multiple rarebit test seemed to be highly capable of detecting neurovisual dysfunction. Its simplicity and uniquely short duration indicate a useful role in screening settings. The test is available free on the Internet. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references.Ophthalmology 04/2013; 120(9). DOI:10.1016/j.ophtha.2013.01.062 · 6.17 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Purpose. There is a need for efficient self-tests of vision in patients with neovascular age-related macula degeneration. A new tablet/smartphone application aiming to meet this need is described and its performance is assessed in a longitudinal pilot study. Materials and Methods. The new MultiBit Test (MBT) employs segmented digits defined by rarebits, that is, receptive field-size bright dots briefly presented against a dark background. The number of rarebits per digit segment was varied in a cyclic fashion, in preset steps. There were no fixation demands. Twenty-eight patients with neovascular AMD of varying severity were monitored for an average of 30 weeks. Test scores were evaluated on an individual basis, by contrasting observed trends with the clinical status recorded at independently scheduled clinical examinations. Results. Serial plots of MBT results revealed gradual improvement after successful antineovascular treatment. Recurrences were signalled by gradual deteriorations of results. Test results remained stable during clinically stable time intervals. MBT results agreed well with clinical assessments whereas an acuity test performed at chance level. The MBT was well accepted by all subjects. Conclusions. The MBT appears to have a good potential for effective self-testing of vision in AMD and merits large-scale studies. Exploration of MBT performance with other forms of macula conditions may be worthwhile.Journal of Ophthalmology 01/2015; 2015:1-7. DOI:10.1155/2015/285463 · 1.94 Impact Factor